Myristoyl Nonapeptide-3

God

Peptide

Myristoyl Nonapeptide-3 at a glance

  • Synthetic peptide
  • Also known as SpecPed® MN3P as well as RetinoPeptide 189
  • Manufacturer claims it mimics retinoic acid
  • Independent research is lacking

Myristoyl Nonapeptide-3 description

Myristoyl nonapeptide-3, known by the trade name SpecPed® MN3P, is a synthetic peptide designed to have anti-aging benefits. . It is also marketed by Symrise under the trade name RetinoPeptide 189. At the time of this writing, there is little independent research regarding its efficacy. The manufacturer of this peptide claims it works by mimicking retinoic acid to encourage cell turnover and collagen synthesis. We will update this definition if/when more third-party studies are published. Supplier-recommended use levels of myristoyl nonapeptide-3 range from 0.005% and 0.05%.

Myristoyl Nonapeptide-3 references

  • UL Prospector, Website, Accessed February 2025

Peer-reviewed, substantiated scientific research is used to assess ingredients in this dictionary. Regulations regarding constraints, permitted concentration levels and availability vary by country and region.

Ratings af ingredienser

Bedst

Dokumenteret og understøttet af uafhængige studier. Fremragende aktiv ingrediens til de fleste hudtyper eller hudproblemer.

God

Nødvendigt for at forbedre en formulerings tekstur, stabilitet eller penetration.

Middel

Generelt ikke-irriterende, men kan have kosmetiske, stabilitetsmæssige eller andre problemer, der begrænser dets anvendelighed.

Dårlig

Der er risiko for irritation. Risikoen øges, når det kombineres med andre problematiske ingredienser.

Dårligst

Kan forårsage irritation, inflammation, tørhed osv. Kan være en fordel i nogle tilfælde, men generelt har man påvist, at ingrediensen gør mere skade end gavn.

Ukendt

Vi kunne ikke finde denne ingrediens i vores ingrediensordbog. Vi registrerer alle manglende ingredienser og foretager løbende opdateringer.

Ikke ratet

Vi har endnu ikke ratet denne ingrediens, fordi vi ikke har haft mulighed for at gennemgå forskningen om den.